Akshara Raghavendra, M.D., M.S.

Peer-Reviewed Articles

1. Mouabbi J, Raghavendra AS, Bassett R, Hassan A, Tripathy D, Layman RM. Survival outcomes in HR+ HER2-low versus HR+ HER2 0 metastatic breast cancer treated with targeted therapies plus endocrine therapy. JAMA Network Open.

Abstracts

1. Raghavendra AS, Bassett R, Mouabbi J, Layman RM, Tripathy D.. Biology and clinical course of lobular cancer in breast cancer. Cancer Research 83(5 Supplement), 2023.
2. Kaler A, Raghavendra AS, Kirklin GT, Cunningham D, Manzullo E, Tripathy D, Razouki Z.. Linking Internal Medicine Care to Metastatic Breast Cancer Patients for Success: LIMBS. Cancer Research 83(5 Supplement), 2023.
3. Raghavendra AS, Liu D, Mouabbi J, Tripathy D. Prevalence of HER2-low among Metastatic Breast Cancer Patients and Their Outcomes Compared to HER2 IHC 0. Cancer Research 83(5 Supplement), 2023.